GBS Inc. Announces Executive Leadership Changes to Accelerate Product Development and Manufacturing

NEXT STORY
MEDIA ALERT: Codex DNA Customer to Highlight Advantages of Automated BioXp™ System in Precision Cancer Immunotherapy Applications at 13th Annual PEGS Europe Protein and Antibody Engineering Summit
PREV STORY
Statera Biopharma Honors Pancreatic Cancer Awareness Month
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

AnaptysBio To Present Data from ANB020 Phase 2a Atopic Dermatitis Trial at AAD Annual Meeting

SAN DIEGO, Feb. 07, 2018 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq:ANAB), a clinical-stage biotechnology ...

author_avatar
NASDAQ Market News

Altimmune Restructures Financing Agreement

GAITHERSBURG, Md., June 22, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq:ALT), a clinical-stage immunotherapeutics ...

author_avatar
NASDAQ Market News

Bionik Laboratories Announces Option to License Robotics Technology from the University of Texas at Dallas

TORONTO and BOSTON, March 30, 2017 (GLOBE NEWSWIRE) -- Bionik Laboratories Corp. (OTCQX:BNKL) (“Bionik” ...

author_avatar
NASDAQ Market News